Semaglutide: A Revolutionary Drug for Obesity Treatment – Here’s What You Need to Know

Weight Loss

Primo Health Partners

PRIMO Health Partners

Professional Resource for Independent Medical Opinions


Obesity is a major health concern worldwide and is linked to several chronic diseases such as type 2 diabetes, cardiovascular disease, and some cancers. Despite numerous efforts to address obesity, it remains a prevalent and challenging health issue. In June 2021, a revolutionary drug, Semaglutide, was approved by the US Food and Drug Administration (FDA) for the treatment of obesity. Here are the benefits of Semaglutide, and what you need to know about Semaglutide injections for weight loss.

Semaglutide Has Received FDA Approval – Why That Matters

In June 2021, the FDA approved Semaglutide for the treatment of obesity. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that work by increasing insulin secretion and suppressing glucagon, which leads to a reduction in blood glucose levels. Semaglutide has been used for the treatment of type 2 diabetes for several years, but its recent approval for obesity treatment is a significant development.

The FDA’s approval of Semaglutide for obesity is based on the results of the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trials. The trials involved over 4,500 participants with obesity and demonstrated that Semaglutide led to significant weight loss, with an average reduction of 15-20% of body weight over 68 weeks. Moreover, Semaglutide was found to be safe and well-tolerated.

Semaglutide Suppresses Appetite

One of the key benefits of Semaglutide is its ability to suppress appetite. Semaglutide works by activating GLP-1 receptors in the brain, which leads to a decrease in hunger and an increase in satiety. This makes it easier for people with obesity to follow a calorie-restricted diet, which is essential for sustained weight loss.

The appetite-suppressing effects of Semaglutide have been demonstrated in several clinical trials. For example, in the STEP 1 trial, participants who received Semaglutide lost an average of 15% of their body weight, compared to only 2.4% for those who received a placebo. Furthermore, the Semaglutide group reported a significant reduction in hunger, cravings, and food intake.

Known Side Effects Are Mild

Semaglutide is generally well-tolerated, and the side effects are mild. The most common side effects reported in clinical trials include nausea, vomiting, diarrhea, and constipation. These side effects usually subside after a few days or weeks of treatment. Rare but serious side effects include acute pancreatitis, gallbladder disease, and kidney problems.

It is essential to discuss the potential risks and benefits of Semaglutide with your healthcare provider before starting treatment. Your healthcare provider will help you determine if Semaglutide is the right treatment for you and monitor your progress regularly.

Get Started With Semaglutide Injection for Weight Loss With PRIMO Health Partners

If you are interested in starting Semaglutide treatment for weight loss, PRIMO Health Partners can help. PRIMO Health Partners is a leading healthcare provider that specializes in Semaglutide injections for weight loss to help you lose weight and feel great. Get in touch with us today to learn more about our online telehealth program and get started.

Recent Articles